All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First in-human, non-invasive femtosecond laser trabeculotomy data ➤ Special Protocol Assessment received for Phase 2b/3 trial for dry AMD treatment ➤ FDA gives clearance to IND for geographic atrophy treatment ➤ Positive preliminary data in trial for retinitis pigmentosa and Leber congenital amaurosis therapy ➤ Wet AMD treatment proceeds to Phase 2 trial ➤ ASCRS news and events
When preparing for second eye cataract surgery, there are a couple of primary factors to consider. Two ophthalmologists who have studied how patient perceptions differ between the first and second procedures talked about what they found and how to discuss this with patients.
➤ Fast-Track Designation granted for persistent epithelial defect treatment ➤ Study: automated capsulotomy device and white cataracts ➤ Dose escalation complete for Phase 1/2 study evaluating an RP treatment ➤ Companies enter agreement for sustained-release glaucoma treatment ➤ ASCRS news and events
As advanced-technology IOLs have become more mainstream and more enter the market, surgeons have refined their understanding and use of these. The EyeWorld
Image quality (IQ) is an emerging area of interest in the field of ophthalmology, and it all starts with what the patient’s image quality is at the outset, according to two physicians. They spoke about their preoperative IQ assessment and why they think this is so important.
Even with a successful cataract surgery, there are a variety of issues that can pop up postoperatively that can be problematic for patients, warranting further follow-up from the physician. Two physicians discussed some of the most common issues that they see following cataract surgery and how to address them.
Cataract Editor Mitchell Weikert, MD, offers a glimpse into what readers will find in both the ASCRS Annual Meeting Preview section and the Cataract section of the issue.
➤ Positive preclinical results for non-viral gene therapy platform ➤ Real-world data confirms efficacy of investigational LHON therapy ➤ Largest genome wide study of photoreceptor cells to date ➤ CDC continues to investigate infectious outbreak associated with artificial tear use ➤ Updates from AAV-based gene therapy program for retinal conditions ➤ ASCRS news and events
➤ NDA submitted for sustained-release travoprost implant ➤ BLA for wet AMD, DME, DR treatment accepted with priority review ➤ Topline results from 12-month safety clinical trial for investigational dry eye drug ➤ Companies collaborate for research on sustained release for investigational GA drug ➤ ASCRS news and events
➤ First FDA-approved treatment for geographic atrophy ➤ FDA accepts NDA for presbyopia drop ➤ NDA for geographic atrophy drug accepted with priority review ➤ Study: 5-year visual field data with MIGS device ➤ ASCRS news and events